Fatty Acid Composition and Oxidative Stress Parameters in Plasma after Fish Oil Supplementation in Aging by Popović, Tamara et al.
 
* Author to whom correspondence should be addressed. (E-mails: poptam@gmail.com & poptam@imi.bg.ac.rs) 
CROATICA CHEMICA ACTA 
CCACAA, ISSN 0011-1643, e-ISSN 1334-417X 
Croat. Chem. Acta 87 (3) (2014) 207–212. 
http://dx.doi.org/10.5562/cca2405 
Original Scientific Article 
Fatty Acid Composition and Oxidative Stress Parameters in Plasma after 
Fish Oil Supplementation in Aging 
Tamara B. Popović,a,* Sunčica Z. Borozan,b Marija M. Takić,a Milica J. Kojadinović,a Slavica 
Rankovic,a Marija Ranić,a and Silvio R. de Lukac 
aInstitute for Medical Research, University of Belgrade, Serbia 
bFaculty of Veterinary Medicine, University of Belgrade, Serbia 
cInstitute for Patological Physiology, Faculty of Medicine, University of Belgrade, Serbia 
RECEIVED NOVEMBER 20, 2013; REVISED JUNE 3, 2014; ACCEPTED JUNE 12, 2014 
 
Abstract. Fish oil affects oxidative stress parameters and changes in phospholipids fatty acids profiles in 
plasma, erythrocytes and tissues. We examined the effects of fish oil supplementation in young and old 
male Wistar rats (3 and 22 months old) on plasma phospholipids fatty acids profiles and blood oxidative 
stress parameters. Twenty young and twenty aged Wistar rats were randomly divided into four groups (ten 
animals each): two control groups and two supplemented groups treated for 6 weeks with fish oil capsules 
containing 45 mg eicosapentanoic acid (EPA) and 30 mg docosahexanoic acid (DHA). Fish oil supple-
mentation changed the percentage of long chain fatty acids (FAs): the elevated percentage of 
eicosatrienoic acid (ETA, 20:3), eicosapentanoic (EPA, 20:5), docosapentanoic acid (DPA, 22:5), n-3 fat-
ty acids and decreased arachidonic acid (AA, 20:4). However, there were no age-related changes in total 
SH groups, the percentages of palmitic (16:0), palmitoleic (16:1), oleic (18:1 (n-9)) and linoleic acid 
(18:2) in plasma phospholipids and MUFA and they were neither reversed nor prevented by fish oil sup-
plementation. Results showed that fish oil supplementation increased SOD and CAT activities in erythro-
cytes, and PON activity in the blood plasma of both young and aged rats. Furthermore, fish oil supple-
mentation decreased lipid peroxidation (MDA) and nitrite levels in both young and aged rats  
implying better antioxidant protection and a lower level of oxidative pressure after fish oil  
supplementation. Our results suggest that fish oil supplementation is beneficial regarding better antioxi-
dant protection in both young and aged rats, while applied treatment differs in plasma phospholipids FAs  
composition. 
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INTRODUCTION 
Aging is a natural, complex, and multifactor biological 
process. Many of the studies conducted on cultured 
human cells and animals have revealed that aging is 
associated with an impairment of bioenergetic func-
tions, increased oxidative stress, attenuated ability to 
respond to stresses, and increased risk of contracting 
cancers and age-related diseases1 The free radical theory 
of aging states that age-related degenerative processes 
are to a large extent a consequence of damage induced 
by free radicals.2,3 
Several changes are associated with aging, in-
cluding a reduced capacity to use oxygen along with 
an impaired cardio circulatory capacity and respirato-
ry adaptation, deterioration of the nervous system, and 
degeneration in the muscle mass.4 Dietary fats in 
mammals provide essential fatty acids for membrane 
synthesis, protein modification and signaling com-
pounds.5 High dietary polyunsaturated fatty acids 
series (n-3 PUFA) increase erythrocyte membrane 
susceptibility to peroxidation and lipid products in 
liver or kidney6 as well as antioxidant enzyme activity 
in the blood.7 Despite lacking mitochondria, erythro-
cytes are a target for free radical exposure due to the 
auto-oxidation of hemoglobin under high oxygen 
pressure. Dietary fats greatly modify erythrocyte 
membrane composition affecting their susceptibility 
to oxidation.8 
The generation of reactive oxygen species (ROS) 
and reactive nitrogen species (RNS) is a normal process 
in the life of aerobic organisms; in fact, ROS and RNS 
are continually produced as a consequence of aerobic 
metabolism: up to 5 % of oxygen reacting with the res-
piratory chain is incompletely reduced to ROS.9 Aging 
process is remarkably slow, indicating that even the 
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aged animals or elderly have adopted a nearly stable 
state of redox homeostasis.3 
The inverse correlation found between the lifespan 
and n-6/n-3 ratio in membrane phospholipids, suggest 
different effects of n-6 and n-3 PUFA in living sys-
tems.10,11 
The aim of our study was to examine age-related 
fatty acids composition of plasma phospholipids and 
antioxidative enzyme status in the blood after fish oil 
supplementation in Wistar rats and to clearly define 
changes in those parameters induced by age, treatment 
or both. 
 
MATERIALS AND METHODS 
Animals and Diets 
Experiments were carried out on young (3 months old) 
and aged (22 months old) male Wistar rats, individually 
housed in stainless steel cages with wired floors, in a 
room under controlled conditions (12 h light–dark cy-
cles, temperature 22 ± 2 °C). Forty Wistar rats were 
randomly selected for the experimental (n = 10, b.w. 
283 ± 5 g) or the control groups (n = 10, body weight 
278 ± 7 g) for young and the experimental (n = 10, b.w. 
318 ± 4.05 g) or the control group (n = 10, b.w.313 ± 
6.15 g) for aged rats; thus, the groups were matched in 
terms of age and body weight. All experiments were 
conducted following our Institutional guidelines for 
animal research and principles of the European Conven-
tion for the Protection of Vertebrate Animals Used for 
Experimental and Others (Official Daily N. L 358/1-
358/6, 18, December 1986). 
The animals were treated with fish oil for 6 weeks. 
The intervention and control group were on the same 
diet. However, each morning the rats were fed only by 
one briquette, which was saturated for the intervention 
group only with 200 μl of fish oil (daily dose 13.5 mg 
EPA + 9.0 mg DHA/kg b.w.) Thirty minutes after 
breakfast, both the intervention and the control group 
were provided with the same amount of their usual diet 
and water ad libitum until 8 pm. 
Blood samples (6–8 cm3) from all rats were ob-
tained before and after the end of intervention via aorta 
abdominalis puncture and collected in tubes containing 
Na-citrate (3.8 % w/v) as anticoagulant. Erythrocytes 
were separated by centrifuge (1300 g) and washed in 
saline solution three times, and the enzyme activities 
were determined. 
 
Antioxidative Parameters Determination 
Antioxidative potential in erythrocytes and plasma was 
determinated via CAT and SOD activities, MDA 
(malondialdehide concentration), nitrites concentration, 
SH groups determinations and PON1 activity. 
The CAT activity in erythrocytes was determined 
following standard procedures.12 One unit of CAT activ-
ity was defined as the activity required for degradation 
of 1 mol H2O2 for 60 s at 25 °C and pH 7.0. Activity 
was expressed as U/gHb. The SOD activity in erythro-
cytes was determined using Calbichem’s Superoxide 
Assay Kit which utilizes 5,6,6a,11b-tetrahydro-3,9,10-
trihydroxybenzo[c]fluorine, recording at 525 nm.13 SOD 
activity was also expressed as U/g Hb. MDA in erythro-
cytes was quantified by measuring the formation of 
thiobarbituric acid reactive substances (TBARS)14,15 and 
expressed in nM MDA/g Hb. The total Hb content was 
measured by the cyanmethemoglobin method.16 Nitrite 
ion (NO2) levels in plasma were analyzed using the 
ELISA method and Griess reagent.17,18 Absorbance was 
measured on a micro plate reader (Plate reader Mod. 
A1; Nubenco Enterprises Inc, Paramus, NJ, USA) at a 
wavelength of 545 nm.Obtained results were expressed 
as l M/l. Free sulfhydryl groups were assayed in plasma 
according to the method described by Ellman et al.19 
The concentration of total SH groups was expressed as 
μM/L. 
The PON1 activity in the plasma was assayed by a 
slightly modified method of hydrolysis of paraoxon.6 
Briefly, the plasma sample was added to 0.1 M Tris–
HCl buffer, pH 8.0 containing 2.0 mM paraoxon (O,O-
diethyl-O-p-nitrophenylphosphate; Sigma Chemical Co, 
London, UK) as a substrate, 2.0 mM CaCl2 and 1 mM 
NaCl. The formation of p-nitrophenol was monitored 
bichromatically at 410/480 nm at 37 °C on Olympus 
AU600, (Dallas, TX, USA). The PON1 activity was 
expressed in international units (U/l) as the amount of 
substrate hydrolyzed per minute and per liter of plasma 
(lmol/min/l). 
Enzyme activities (CAT, SOD, PON1) were 
measured on CECIL CE 2021 UV/VIS spectrophotome-
ter (BMG LabTech GmbH, Offenburg, Germany), while 
electrophoresis was performed on a vertical device Mini 
Ve Hoffer, (LKB 2117; Bromma, Uppsala, Sweden).19,20 
 
Fatty Acid Analysis  
Plasma phospholipids were extracted using chloro-
form/methanol mixture (2:1, v/v) with 50 mg/100ml 2, 
6-di-tert-butyl-4-methylphenol (BHT) added as antioxi-
dant. 
The phospholipids fraction was isolated from the 
extracted lipids by one-dimensional (TLC) neutral lipid 
solvent system of hexane:diethyl ether:acetic acid 
(87:2:1) using Silica Gel GF plates (C. Merck, Darm-
stadt, Germany). The phospholipid fraction was scraped 
into glass tubes and phospholipid FAs methyl esters 
were prepared by transmethylation with sodium hydrox-
ide (2 mol/dm3) in methanol (heated at 85 °C for 1 h) 
and after that by sulfuric acid (1 mol/dm3) in methanol 
(heated 85 °C for 2 h). After 30 minutes, samples of 
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esters were centrifuged, upper phases were put into 
tubes and evaporated with technical nitrogen. FAs me-
thyl esters derivatives formed from isolated plasma 
phospholipids fraction were separated by Gas Chroma-
tography (GC) using Shimadzu GC 2014 equipped with 
a flame ionization detector and DB-23 fused silica gel 
capillary column. The flame ionization detector was set 
at 250 °C, the injection port at 220 °C, and the oven 
temperature was programmed from 130 to 190 °C at the 
heating rate of 3°C/min. Comparing sample peak reten-
tion times with authentic standards (Sigma Chemical 
Company) and/or the (PUFA)-2 standard mixtures 
(Restec) identified individual FAs methyl esters.21,22 
 
Statistical Analysis 
Data are expressed as the means ± SD. Statistical signif-
icance was tested with two-way ANOVAs using the age 
of animals and treatment as factors on logarithmic or 
trigonometric transformed data. The trends were con-
sidered as significant if p < 0.05. The values were post 
hoc compared by Tukey HSD test. 
 
RESULTS 
The results of the study are expressed as age-related or 
not aged-related and dependent or not dependent on fish 
oil supplementation. 
Regarding phospholipids fatty acids profiles, there 
were no age-related changes in 18:1, n-7 (vascenic ac-
id), 18:2 (LA), 20:4 (ETA), 20:5 (EPA), 22:4 (DTA), 
22:5 (DPA) and 22:6 (DHA) (Figures 1 and 2). Aging 
did not influence SFA and PUFA; however age-related 
changes were found on overall MUFA and n-6/n-3 ratio. 
(Figures 3 and 4). 
Fish oil supplementation changed the percentages 
of stearic acid (18:0), vascenic acid (18:1,n-7), ETA 
(20:3), AA (20:4), EPA (20:5) and DPA (22:5); how-
ever, supplementation did not change the percentages 
of palmitic acid (16:0), palmitoleic acid (16:1), oleic 
acid (18:1, n-9), 18:2 (LA), and docosahexanoic acid 
(22:6) (Figures 1 and 2). A decrease in n-6/n-3 ratio 
and an increase in n-3 fatty acids with no changes in n-
Figure 1. The percentage of palmitic acid (16:0), palmitoleic
(16:1), stearic (18:0), vascenic (18:1,n7) and linoleic acid
(18:2) in plasma phospholipids of young and aged rats sup-
plemented by fish oil. Results were tested by two-way ANO-
VA with age (A) and supplementation (S) factors; F values
and p significance were showed. 
 
Figure 2. The percentage of ETA (20:3), AA (20:4), EPA 
(20:5), DTA (22:4), DPA (22:5) and DHA (22:6) in plasma 
phospholipids of young and aged rats supplemented by fish 
oil. Results were tested by two-way ANOVA with age (A) and 
supplementation (S) factors; F values and p significance were 
showed. 
Figure 3. SFA (saturated fatty acids), MUFA (monounsaturat-
ed fatty acids) and PUFA (polyunsaturated fatty acids) per-
centage in plasma phospholipids of young and aged rats sup-
plemented by fish oil. Results were tested by two-way ANO-
VA with age (A) and supplementation (S) factors; F values 
and p significance were showed. 
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6 fatty acids were further consequences of supplementa-
tion. 
Results showed that fish oil supplementation led 
to increased activities of SOD and CAT in erythrocytes, 
and PON activity in serum of both young and aged rats 
(Figure 5; significant supplementation effect p < 0.001). 
Furthermore, supplementation decreased MDA and 
nitrite levels in both young and aged rats (Figure 6; 
significant supplementation effect p < 0.001). A de-
crease in nitrites concentration was more profound in 
aged rats (significant p < 0.001 interaction A × S effect 
in ANOVA, Figure 6). Fish oil supplementation had no 
effect on the level of total SH groups (Figure 6). 
Our results suggest that fish oil supplementation 
was beneficial regarding better antioxidant protection 
and a lower level of oxidative stress. 
 
DISCUSSION 
The relationships between body size, energy metabo-
lism and lifespan have been analysed elsewhere 
(Speakman et al. 2005).23 The conclusion in Speak-
man’s study was that there must be other factors to 
account for species’ differences in maximum lifespan. 
One of the factors is that membrane composition corre-
lates with maximum lifespan in mammals and birds.23 In 
the determination of longevity, FAs composition is an 
important factor for three basic reasons: 1) membrane 
FAs varies among species, 2) FA differ in their suscep-
tibility to peroxidation and 3) many products of lipid 
peroxidation are powerful ROS.7 
Polyunsaturated fatty acids of n-3 and n-6 families 
play multiple roles in mammals. They are rapidly incor-
porated into cell membranes and influence many biolog-
ical functions from membrane fluidity, activation of 
intracellular pathways directly or via production of 
eicosanoids, to gene expression and cell differentia-
tion.24 Fish oil which we used in the supplementation 
treatment consists of two polyunsaturated fatty acids 
EPA and DHA. 
EPA acts as a precursor for prostaglandin-3 inhibi-
tor of platelet aggregation, thromboxane-3 and leukotri-
ene-5 groups (all eicosanoids), partially blocking the 
conversion of n-6 FA to harmful eicosanoids, thereby 
reducing the cardiovascular risk and inhibiting tumour 
genesis.11,25 DHA plays a role in the development of brain 
Figure 4. Fatty acids ratio (n-6/n-3) in plasma phospholipids
of young and aged rats supplemented by fish oil. Results were
tested by two-way ANOVA with age (A) and supplementation
(S) factors; F values and p significance were showed. 
Figure 5. SOD (superoxide dismutase) and CAT (catalase)
activity in erythrocytes and PON (paraoxonase) activity in the
blood plasma of young and aged rats supplemented by fish oil.
Results were tested by two-way ANOVA with age (A) and
supplementation (S) factors; F values and p significance were
showed. (*PON activity, mol/min/L) 
 
Figure 6. The concentration of MDA (malondialdehyde), 
nitrites and total SH (thiol) groups in the blood plasma of 
young and aged rats supplemented by fish oil. Results were 
tested by two-way ANOVA with age (A) and supplementation 
(S) factors; F values and p significance were showed. (*MDA, 
U/gHb; *SH groups, μM/L;*nitrites, mol/L) 
T. B. Popović et al., Antioxidative Role of Fish Oil in Experimental Model of Aging 211 
Croat. Chem. Acta 87 (2014) 207. 
tissue and is important in maintaining cognitive health in 
the human population.24 DHA regulates cell transport and 
synaptic functions.26 n-3 PUFAs increase the activity of 
lipoprotein lipase and improve reverse cholesterol 
transport. Its imunomodulatory effects are involved in the 
suppression T-lymphocytes activation.27,28 
There are variations in FAs composition among 
species. Correlations between birds and mammals in n-6 
and n-3 were discussed by some authors. 
Although the membrane FAs composition is relat-
ed to the body mass of birds and mammals, their FAs 
composition differs. In birds, balance n-6/n-3 is shifted 
to n-6 PUFA which correlates with the relatively long 
lifespan of birds.7 
In our study the percentage of EPA significantly 
increased after fish oil supplementation, while the per-
centage of DHA did not change. However, overall n-3 
plasma phospholipids increased after supplementation, 
while n-6/n-3 ratio decreased significantly. Possible 
explanation for this could be the starting percentage of 
EPA which was lower than the starting percentage of 
DHA. Supplementation increased EPA levels and its 
incorporation more efficiently than DHA. 
Supplementation elevated the percentage of stearic 
acid (18:0), ETA, (20:3), EPA (20:5), DPA (22:5) (Fig-
ures 1 and 2), n-3 fatty acids (Figure 4) and decreased 
AA (20:4) (Figure 2). However, no age-related changes 
in the percentage of palmitic acid (16:0), palmitoleic 
(16:1), oleic acid (18:1 (n-9)), linoleic acid (18:2) (Fig-
ure 2) and MUFA profiles (Figure 3) were either re-
versed or prevented by fish oil supplementation. FAs in-
corporation is also tissue dependent and sometimes it is 
more efficient in tissues or erythrocytes than in plasma. 
Incorporation of PUFA into phospholipids leads to 
conformational changes and lowered availability of 
double bonds for lipoperoxidation.29 
Contrary to our findings, examinations of Hsu et 
al.10 showed that dietary supplementation with n-3 
PUFA had no effect on lipid membrane peroxidation or 
had a positive effect on glutathione level and 
antioxidative enzymes activity. The question that re-
mains unclear is if the increased sensitivity of mem-
branes to lipid peroxidation (or the increased quantity of 
lipid peroxidation products) is a result of increased ROS 
activation from phagocytes or dysfunction of AOS in 
the blood or both.10 Erythrocytes are attacked with ROS 
considering auto oxidation of hemoglobin influenced by 
high oxygen pressure in the arterial blood. Increased 
ROS in erythrocytes leads to membrane lipid peroxida-
tion and can damage other intracellular proteins.2 
Intensive lipid peroxidation decreases the fluidity 
of biological membranes, increases ionic permeability 
and leads to the inactivation of enzymes in the mem-
brane. Also, lipid peroxidation decreases membrane 
potential, increases permeability for hydrogen ions and 
increases damage of cells. 
After fish oil supplementation, lipid peroxidation 
(MDA) and nitrites concentration decreased in both 
young and aged rats (Figure 6; significant supplementa-
tion effect p < 0.001). The decrease in nitrites concen-
tration was more profound in aged rats (significant p < 
0.001 interaction A × S effect in ANOVA, Figure 6). 
Fish oil supplementation had no effect on the level of 
total SH groups (Figure 6). 
In the study of Gamba et al. fish oil supplementa-
tion was unable to protect against the natural age-
induced modification in renal hemodynamics and was 
unable to reduce lipoprotein concentration in patients 
with chronic glomerular disease.30 In young animals, 
renal hemodynamics is not controlled by eicosanoids, 
but with age it becomes dependent on vasodilatory pros-
taglandins (PG) and the renal vasoconstrictor effect of 
thromboxane A2.  
In the study of Oarada et al., Wistar rats received 
EPA or DHA by gavage.The treatment increased EPA 
and DHA, and itdecreased AA and n-6/n-3 ratio in 
plasma phospholipids membranes.8 
It should be mentioned that NO can play a multi-
faceted role in the regulation of the mitochondrial ROS 
generation in young and aged Wistar rats.31  
In the study of Lukiw et al., plasma nitrates con-
centration was increased in aged and SH rats.26 Early 
decline in eNOS activity and protein expression was not 
found in WKY but was found in SH rats.17 In the aging 
process, a decreased eNOS activity was observed in 
WKY, while iNOS increased in the same group of ani-
mals. The higher basal levels of NO2/NO3 may result 
from higher expression of iNOS in SH rats17 and proba-
bly in aged Wistar rats, too. Impaired NO bioavailability 
in aging may contribute to age-related alterations in the 
mitochondrial mass in blood vessels.32 RNS markers 
(NOx and nitrotyrosine) in the blood and some tissues 
increased from young to middle-aged rats but decreased 
from middle aged to old aged rats.33,34  
In the study of Hamden et al., aging significantly 
decreased SOD, CAT and GSH-Px and increased LDH, 
GGT AST, ALT in the liver35 Prooxidative/antio-
xidative balance in erythrocytes is important for other 
tissues considering erythrocytes as mobile detoxified 
elements in circulation.36,37 
Our results showed that fish oil supplementation 
led to increased SOD and CAT activities in erythro-
cytes, and PON activity in the plasma of both young and 
aged rats (Figure 5; significant supplementation effect  
p < 0.001). 
Primary high reactive intermediers occur during 
lipid peroxidation. Their degradation leads to aldehydes 
which react with amino-groups of proteins changing 
their structural and functional properties.38,39 Sarsilmaz 
et al. 2003 showed that treatment with n-3 FA decreased 
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lipid peroxidation in corpus striatum in rats. Dietary 
supplementation with fish oil can increase antioxidative 
defense and reduce lipid peroxidation.38 Supplementa-
tion of n-3 FAs contributes to the preservation of eryth-
rocyte membranes, their structure, fluidity and function-
ality in rats of different ages.40 
 
CONCLUSION 
Fish oil supplementation changes plasma phospholipids 
profiles in the blood plasma elevating ETA, EPA, DPA, 
n-3 and decreasing the percentage of AA. Age-related 
changes of total SH, the percentage of palmitic, 
palmitoleic and oleic acids in plasma phospholipids and 
MUFA were neither reversed nor prevented by fish oil 
supplementation. SOD, CAT activities in erythrocytes 
and PON activity in the plasma were increased in both 
young and aged rats. Decrease of MDA and nitrites 
levels after fish oil supplementation was present in 
young and aged rats. Our results suggest that fish oil 
supplementation is beneficial regarding better antioxi-
dant protection lowering the level of oxidative stress in 
both young and aged rats. 
Abbreviations: EPA = eicosapentanoic acid, DHA = docosa-
hexanoic acid, Fas = fatty acids, ETA = eicosatrienoic acid, 
DPA = docosapentanoic acid, AA = arachidonic acid, LA = 
linoleic acid, PUFA = polyunsaturated fatty acids, MUFA = 
monounsaturated fatty acids, SFA = saturated fatty acids, NO 
= nitric oxide, SOD = superoxide dismutase, CAT = catalase, 
PON = paraoxonase, MDA = malondiadehyde, ROS = reac-
tive oxidative species, RNS = reactive nitric species, AOS = 
antioxidative system 
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